Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
6.09
-0.03 (-0.49%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $1.05 billion as of April 29, 2026. Its market cap has increased by 72.70% in one year.
Market Cap
1.05B
Enterprise Value
1.20B
1-Year Change
72.70%
Ranking
Category
Stock Price
$6.09
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $1.05B, an increase of 255.03%. That is a compound annual growth rate of 32.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.06B | -18.98% |
| Dec 31, 2025 | 1.30B | 157.72% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| uniQure | 1.14B |
| Septerna | 1.11B |
| Zenas BioPharma | 1.08B |
| Inventiva | 1.06B |
| ORIC Pharmaceuticals | 1.03B |
| KalVista Pharmaceuticals | 1.01B |
| Omeros | 974.11M |
| Geron | 961.35M |